Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Diamond-Blackfan Anemia
Related studies linked through entity extraction aliases.
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Familial Investigations of Childhood Cancer Predisposition
- Status
- RECRUITING
- Phase
- N/A
Investigation of the Genetics of Hematologic Diseases
- Status
- RECRUITING
- Phase
- N/A
Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
- Status
- TERMINATED
- Phase
- PHASE2
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- Status
- COMPLETED
- Phase
- PHASE1
Multi-Center Study of Iron Overload: Survey Study (MCSIO)
- Status
- COMPLETED
- Phase
- N/A
Human Placental-Derived Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
Multi-Center Study of Iron Overload: Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs
- Status
- COMPLETED
- Phase
- PHASE2
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload
- Status
- COMPLETED
- Phase
- PHASE4
Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- NA
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
- Status
- COMPLETED
- Phase
- NA
Stem Cell Transplant for Bone Marrow Failure Syndromes
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3